High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice

Dongming Cui, Zina Moldoveanu, Charles B. Stephensen

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Vitamin A supplementation during acute pneumonia has not improved recovery in most human clinical trials. We hypothesize that high vitamin A intake may decrease the production of T-helper type-1 (Th1) cytokines and thereby inhibit antiviral responses. Such decreases might impair recovery from viral respiratory infections. We thus examined the effect of three interventions on viral pneumonia: 1) a high level vitamin A [250,000 IU/kg diet or 75,000 retinol equivalents (RE)/kg], or 2) control diet (4000 IU/kg diet or 1200 RE/kg) given before and during infection, and 3) initiating the high level diet upon infection to simulate the adjuvant therapy used in clinical trials. No difference was seen among the interventions in severity of disease (weight loss, lung virus titers and survival). However, both the high level diet group and the group in which vitamin A was increased at the time of infection had greater salivary immunoglobulin (Ig)A responses (geometric means, 166 and 105 μg/L, respectively) than did the control group (59 μg/L) (P = 0.0019). In contrast, the serum IgG response was higher in the control group (324 (+) 158 mg/L) than in the high level group (225 (+) 95 mg/L) (P = 0.028), although it did not differ from the group in which the diet was changed upon infection (230 (+) 163 mg/L) (P = 0.084). The production of interferon-γ (IFN-γ), a Th1 cytokine, was lower in the high level diet group (median, 0.153 μg/L) compared with the control group (median, 0.839 μg/L) (P = 0.014), whereas the production of interleukin-10 (IL-10), a Th2 cytokine, was higher with the high level diet (median, 0.304 μg/L) than with the control (median, 0.126 μg/L) (P = 0.022). This change in the Th1/Th2 pattern was not sufficient to affect recovery from viral pneumonia but may account for the increased IgA and decreased IgG responses seen with high level dietary vitamin A in this study. These data reinforce the lack of utility of vitamin A in treating acute pneumonia in children and suggest that high dose vitamin A supplements may enhance Th2-mediated immune responses, which are particularly beneficial in the case of extracellular bacterial and parasitic infections and IgA-mediated responses to mucosal infections.

Original languageEnglish (US)
Pages (from-to)1132-1139
Number of pages8
JournalJournal of Nutrition
Volume130
Issue number5
StatePublished - 2000

Fingerprint

Secretory Immunoglobulin A
immunoglobulin A
Influenza A virus
Virus Diseases
Vitamin A
vitamin A
cytokines
Cytokines
Diet
mice
infection
diet
viral pneumonia
Viral Pneumonia
Immunoglobulin A
Infection
Control Groups
pneumonia
clinical trials
Pneumonia

Keywords

  • Immunoglobulin A
  • Influenza A virus
  • Interferon-γ
  • Interleukin-10
  • Mus musculus
  • Pneumonia
  • Vitamin A

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice. / Cui, Dongming; Moldoveanu, Zina; Stephensen, Charles B.

In: Journal of Nutrition, Vol. 130, No. 5, 2000, p. 1132-1139.

Research output: Contribution to journalArticle

@article{3f99a194cd424f4abef34b2f9cf9d7ed,
title = "High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice",
abstract = "Vitamin A supplementation during acute pneumonia has not improved recovery in most human clinical trials. We hypothesize that high vitamin A intake may decrease the production of T-helper type-1 (Th1) cytokines and thereby inhibit antiviral responses. Such decreases might impair recovery from viral respiratory infections. We thus examined the effect of three interventions on viral pneumonia: 1) a high level vitamin A [250,000 IU/kg diet or 75,000 retinol equivalents (RE)/kg], or 2) control diet (4000 IU/kg diet or 1200 RE/kg) given before and during infection, and 3) initiating the high level diet upon infection to simulate the adjuvant therapy used in clinical trials. No difference was seen among the interventions in severity of disease (weight loss, lung virus titers and survival). However, both the high level diet group and the group in which vitamin A was increased at the time of infection had greater salivary immunoglobulin (Ig)A responses (geometric means, 166 and 105 μg/L, respectively) than did the control group (59 μg/L) (P = 0.0019). In contrast, the serum IgG response was higher in the control group (324 (+) 158 mg/L) than in the high level group (225 (+) 95 mg/L) (P = 0.028), although it did not differ from the group in which the diet was changed upon infection (230 (+) 163 mg/L) (P = 0.084). The production of interferon-γ (IFN-γ), a Th1 cytokine, was lower in the high level diet group (median, 0.153 μg/L) compared with the control group (median, 0.839 μg/L) (P = 0.014), whereas the production of interleukin-10 (IL-10), a Th2 cytokine, was higher with the high level diet (median, 0.304 μg/L) than with the control (median, 0.126 μg/L) (P = 0.022). This change in the Th1/Th2 pattern was not sufficient to affect recovery from viral pneumonia but may account for the increased IgA and decreased IgG responses seen with high level dietary vitamin A in this study. These data reinforce the lack of utility of vitamin A in treating acute pneumonia in children and suggest that high dose vitamin A supplements may enhance Th2-mediated immune responses, which are particularly beneficial in the case of extracellular bacterial and parasitic infections and IgA-mediated responses to mucosal infections.",
keywords = "Immunoglobulin A, Influenza A virus, Interferon-γ, Interleukin-10, Mus musculus, Pneumonia, Vitamin A",
author = "Dongming Cui and Zina Moldoveanu and Stephensen, {Charles B.}",
year = "2000",
language = "English (US)",
volume = "130",
pages = "1132--1139",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "5",

}

TY - JOUR

T1 - High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice

AU - Cui, Dongming

AU - Moldoveanu, Zina

AU - Stephensen, Charles B.

PY - 2000

Y1 - 2000

N2 - Vitamin A supplementation during acute pneumonia has not improved recovery in most human clinical trials. We hypothesize that high vitamin A intake may decrease the production of T-helper type-1 (Th1) cytokines and thereby inhibit antiviral responses. Such decreases might impair recovery from viral respiratory infections. We thus examined the effect of three interventions on viral pneumonia: 1) a high level vitamin A [250,000 IU/kg diet or 75,000 retinol equivalents (RE)/kg], or 2) control diet (4000 IU/kg diet or 1200 RE/kg) given before and during infection, and 3) initiating the high level diet upon infection to simulate the adjuvant therapy used in clinical trials. No difference was seen among the interventions in severity of disease (weight loss, lung virus titers and survival). However, both the high level diet group and the group in which vitamin A was increased at the time of infection had greater salivary immunoglobulin (Ig)A responses (geometric means, 166 and 105 μg/L, respectively) than did the control group (59 μg/L) (P = 0.0019). In contrast, the serum IgG response was higher in the control group (324 (+) 158 mg/L) than in the high level group (225 (+) 95 mg/L) (P = 0.028), although it did not differ from the group in which the diet was changed upon infection (230 (+) 163 mg/L) (P = 0.084). The production of interferon-γ (IFN-γ), a Th1 cytokine, was lower in the high level diet group (median, 0.153 μg/L) compared with the control group (median, 0.839 μg/L) (P = 0.014), whereas the production of interleukin-10 (IL-10), a Th2 cytokine, was higher with the high level diet (median, 0.304 μg/L) than with the control (median, 0.126 μg/L) (P = 0.022). This change in the Th1/Th2 pattern was not sufficient to affect recovery from viral pneumonia but may account for the increased IgA and decreased IgG responses seen with high level dietary vitamin A in this study. These data reinforce the lack of utility of vitamin A in treating acute pneumonia in children and suggest that high dose vitamin A supplements may enhance Th2-mediated immune responses, which are particularly beneficial in the case of extracellular bacterial and parasitic infections and IgA-mediated responses to mucosal infections.

AB - Vitamin A supplementation during acute pneumonia has not improved recovery in most human clinical trials. We hypothesize that high vitamin A intake may decrease the production of T-helper type-1 (Th1) cytokines and thereby inhibit antiviral responses. Such decreases might impair recovery from viral respiratory infections. We thus examined the effect of three interventions on viral pneumonia: 1) a high level vitamin A [250,000 IU/kg diet or 75,000 retinol equivalents (RE)/kg], or 2) control diet (4000 IU/kg diet or 1200 RE/kg) given before and during infection, and 3) initiating the high level diet upon infection to simulate the adjuvant therapy used in clinical trials. No difference was seen among the interventions in severity of disease (weight loss, lung virus titers and survival). However, both the high level diet group and the group in which vitamin A was increased at the time of infection had greater salivary immunoglobulin (Ig)A responses (geometric means, 166 and 105 μg/L, respectively) than did the control group (59 μg/L) (P = 0.0019). In contrast, the serum IgG response was higher in the control group (324 (+) 158 mg/L) than in the high level group (225 (+) 95 mg/L) (P = 0.028), although it did not differ from the group in which the diet was changed upon infection (230 (+) 163 mg/L) (P = 0.084). The production of interferon-γ (IFN-γ), a Th1 cytokine, was lower in the high level diet group (median, 0.153 μg/L) compared with the control group (median, 0.839 μg/L) (P = 0.014), whereas the production of interleukin-10 (IL-10), a Th2 cytokine, was higher with the high level diet (median, 0.304 μg/L) than with the control (median, 0.126 μg/L) (P = 0.022). This change in the Th1/Th2 pattern was not sufficient to affect recovery from viral pneumonia but may account for the increased IgA and decreased IgG responses seen with high level dietary vitamin A in this study. These data reinforce the lack of utility of vitamin A in treating acute pneumonia in children and suggest that high dose vitamin A supplements may enhance Th2-mediated immune responses, which are particularly beneficial in the case of extracellular bacterial and parasitic infections and IgA-mediated responses to mucosal infections.

KW - Immunoglobulin A

KW - Influenza A virus

KW - Interferon-γ

KW - Interleukin-10

KW - Mus musculus

KW - Pneumonia

KW - Vitamin A

UR - http://www.scopus.com/inward/record.url?scp=0034012183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034012183&partnerID=8YFLogxK

M3 - Article

VL - 130

SP - 1132

EP - 1139

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 5

ER -